- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Modulation of versican expression by smooth muscle...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Modulation of versican expression by smooth muscle cells and myofibroblasts in cardiovascular disease McDonald, Paul Christopher
Abstract
Aberrant accumulation of proteoglycans, particularly versican, is a hallmark of vascular lesions and is potentially important in the development of myxomatous cardiac valve lesions. My overarching hypothesis is that the dysregulation of proteoglycan expression plays an important role in the pathogenesis of accelerated vascular disease and valvular heart disease. I tested three specific hypotheses relating to this overarching framework. First, that the overexpression of versican by smooth muscle cells (SMCs) is due to modulation of its expression by specific molecules present within the tissue microenvironment. Second, that versican is spatially associated with modified lipoproteins in human atheromatous disease. Third, that the exposure of cardiac valves to certain anorexigens (appetite suppressants) produces a proteoglycan-rich lesion morphologically distinct from lesions characterizing other valve diseases and related to the dysregulation of versican expression by myofibroblasts (MFBs). To address the first hypothesis, growth factor-mediated modulation of versican expression by rat aortic SMCs was examined. Treatment of SMCs with either epidermal growth factor (EGF) or insulin-like growth factor-I (IGF-I) significantly upregulated versican mRNA levels and increased core protein expression. Stimulation of SMCs with a combination of EGF and IGF-I further increased versican expression. The oxidative status of lipoproteins present in coronary arteries from human heart allografts and their localization relative to versican and vessel wall cells were examined to address the second hypothesis. Lipoproteins in mild and severe lesions were oxidatively modified, although certain forms of oxidative modification only appeared in severe lesions. The oxidized lipoproteins were often associated with versican and intimal SMCs. The third hypothesis was addressed by examining the geometric and compositional characteristics of normal and diseased heart valves. Valves excised from patients exposed to anorexigens exhibited a glycosaminoglycan-rich lesion distinct from lesions characterizing other myxomatous valve diseases. The myxomatous process was present in both the valve onlays and the valve proper. Myxomatous regions were rich in versican and MFBs cultured from human cardiac valve tissue expressed versican. In summary, these data provide key insights into the modulation of versican expression and lay the groundwork for future experiments aimed at further understanding the regulation of versican expression and development of potential novel therapies for the treatment of cardiovascular disorders.
Item Metadata
Title |
Modulation of versican expression by smooth muscle cells and myofibroblasts in cardiovascular disease
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2002
|
Description |
Aberrant accumulation of proteoglycans, particularly versican, is a hallmark of vascular
lesions and is potentially important in the development of myxomatous cardiac valve lesions.
My overarching hypothesis is that the dysregulation of proteoglycan expression plays an
important role in the pathogenesis of accelerated vascular disease and valvular heart disease. I
tested three specific hypotheses relating to this overarching framework. First, that the
overexpression of versican by smooth muscle cells (SMCs) is due to modulation of its expression
by specific molecules present within the tissue microenvironment. Second, that versican is
spatially associated with modified lipoproteins in human atheromatous disease. Third, that the
exposure of cardiac valves to certain anorexigens (appetite suppressants) produces a
proteoglycan-rich lesion morphologically distinct from lesions characterizing other valve
diseases and related to the dysregulation of versican expression by myofibroblasts (MFBs). To
address the first hypothesis, growth factor-mediated modulation of versican expression by rat
aortic SMCs was examined. Treatment of SMCs with either epidermal growth factor (EGF) or
insulin-like growth factor-I (IGF-I) significantly upregulated versican mRNA levels and
increased core protein expression. Stimulation of SMCs with a combination of EGF and IGF-I
further increased versican expression. The oxidative status of lipoproteins present in coronary
arteries from human heart allografts and their localization relative to versican and vessel wall
cells were examined to address the second hypothesis. Lipoproteins in mild and severe lesions
were oxidatively modified, although certain forms of oxidative modification only appeared in
severe lesions. The oxidized lipoproteins were often associated with versican and intimal SMCs.
The third hypothesis was addressed by examining the geometric and compositional
characteristics of normal and diseased heart valves. Valves excised from patients exposed to
anorexigens exhibited a glycosaminoglycan-rich lesion distinct from lesions characterizing other
myxomatous valve diseases. The myxomatous process was present in both the valve onlays and the valve proper. Myxomatous regions were rich in versican and MFBs cultured from human
cardiac valve tissue expressed versican. In summary, these data provide key insights into the
modulation of versican expression and lay the groundwork for future experiments aimed at
further understanding the regulation of versican expression and development of potential novel
therapies for the treatment of cardiovascular disorders.
|
Extent |
22828780 bytes
|
Genre | |
Type | |
File Format |
application/pdf
|
Language |
eng
|
Date Available |
2009-11-12
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
|
DOI |
10.14288/1.0091418
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2002-11
|
Campus | |
Scholarly Level |
Graduate
|
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.